Prof. Dr. med. Thomas Oellerich

Prof. Dr. med. Thomas Oellerich is a renowned specialist in Hematology and Oncology who was appointed Director of the Department of Hematology and Oncology at the University Hospital Frankfurt in 2023. With an impressive list of scientific publications, Dr. Oellerich has focused his research on predictive phosphorylation markers for acute myeloid leukemia treatment, biomarkers for cytarabine response, and metabolic plasticity of leukemia cells. Through his work, he has made significant contributions to understanding oncogenic signaling pathways and developing innovative therapeutic approaches. Dr. Oellerich's extensive experience and expertise in hematology and oncology make him a valuable asset in the field. His studies on different types of cancers, including lymphoma and colorectal cancer, have provided valuable insights into the underlying mechanisms of disease progression and resistance to treatment. With a keen focus on personalized medicine and targeted therapies, Dr. Oellerich continues to push the boundaries of cancer research, ultimately aiming to improve patient outcomes and quality of life.